|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sinevici N and O'Sullivan J: Oral cancer:
Deregulated molecular events and their use as biomarkers. Oral
Oncol. 61:12–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Braakhuis BJ, Leemans CR and Visser O:
Incidence and survival trends of head and neck squamous cell
carcinoma in the Netherlands between 1989-2011. Oral Oncol.
50:670–675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi EO, Park C, Hwang HJ, Hong SH, Kim
GY, Cho EJ, Kim WJ and Choi YH: Baicalein induces apoptosis via
ROS-dependent activation of caspases in human bladder cancer 5637
cells. Int J Oncol. 49:1009–1018. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du G, Han G, Zhang S, Lin H, Wu X, Wang M,
Ji L, Lu L, Yu L and Liang W: Baicalin suppresses lung carcinoma
and lung metastasis by SOD mimic and HIF-1alpha inhibition. Eur J
Pharmacol. 630:121–130. 2010. View Article : Google Scholar
|
|
6
|
Chen M, Lai L, Li X, Zhang X, He X, Liu W,
Li R, Ke X, Fu C, Huang Z and Duan C: Baicalein attenuates
neurological deficits and preserves blood-brain barrier integrity
in a rat model of intracerebral hemorrhage. Neurochem Res.
41:3095–3102. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chao JI, Su WC and Liu HF: Baicalein
induces cancer cell death and proliferation retardation by the
inhibition of CDC2 kinase and survivin associated with opposite
role of p38 mitogen-activated protein kinase and AKT. Mol Cancer
Ther. 6:3039–3048. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Ling Y, Chen Y, Li CL, Feng F, You
QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion,
migration and invasion of MDA-MB-231 human breast cancer cells.
Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bie B, Sun J, Guo Y, Li J, Jiang W, Yang
J, Huang C and Li Z: Baicalein: A review of its anti-cancer effects
and mechanisms in Hepatocellular Carcinoma. Biomed Pharmacother.
93:1285–1291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su G, Chen H and Sun X: Baicalein
suppresses non small cell lung cancer cell proliferation, invasion
and Notch signaling pathway. Cancer Biomark. 22:13–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takahashi H, Chen MC, Pham H, Angst E,
King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, et
al: Baicalein, a component of Scutellaria baicalensis, induces
apoptosis by Mcl-1 down-regulation in human pancreatic cancer
cells. Biochim Biophys Acta. 1813:1465–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan W, Ma X, Zhao X and Zhang S: Baicalein
induces apoptosis and autophagy of breast cancer cells via
inhibiting PI3K/AKT pathway in vivo and vitro. Drug Des Devel Ther.
12:3961–3972. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiu YW, Lin TH, Huang WS, Teng CY, Liou
YS, Kuo WH, Lin WL, Huang HI, Tung JN, Huang CY, et al: Baicalein
inhibits the migration and invasive properties of human hepatoma
cells. Toxicol Appl Pharmacol. 255:316–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mu J, Liu T, Jiang L, Wu X, Cao Y, Li M,
Dong Q, Liu Y and Xu H: The traditional chinese medicine baicalein
potently inhibits gastric cancer cells. J Cancer. 7:453–461. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li B, Lu M, Jiang XX, Pan MX, Mao JW and
Chen M: Inhibiting reactive oxygen species-dependent autophagy
enhanced baicalein-induced apoptosis in oral squamous cell
carcinoma. J Nat Med. 71:433–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng YH, Li LA, Lin P, Cheng LC, Hung CH,
Chang NW and Lin C: Baicalein induces G1 arrest in oral cancer
cells by enhancing the degradation of cyclin D1 and activating AhR
to decrease Rb phosphorylation. Toxicol Appl Pharmacol.
263:360–367. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suske G, Bruford E and Philipsen S:
Mammalian SP/KLF transcription factors: Bring in the family.
Genomics. 85:551–556. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi Q, Le X, Abbruzzese JL, Peng Z, Qian
CN, Tang H, Xiong Q, Wang B, Li XC and Xie K: Constitutive Sp1
activity is essential for differential constitutive expression of
vascular endothelial growth factor in human pancreatic
adenocarcinoma. Cancer Res. 61:4143–4154. 2001.PubMed/NCBI
|
|
19
|
Abdelrahim M, Smith R III, Burghardt R and
Safe S: Role of Sp proteins in regulation of vascular endothelial
growth factor expression and proliferation of pancreatic cancer
cells. Cancer Res. 64:6740–6749. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tan NY and Khachigian LM: Sp1
phosphorylation and its regulation of gene transcription. Mol Cell
Biol. 29:2483–2488. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Safe S and Abdelrahim M: Sp transcription
factor family and its role in cancer. Eur J Cancer. 41:2438–2448.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsieh MJ, Chen JC, Yang WE, Chien SY, Chen
MK, Lo YS, His YT, Chuang YC, Lin CC and Yang SF:
Dehydroandrographolide inhibits oral cancer cell migration and
invasion through NF-kB-, AP-1-, and SP-1-modulated matrix
metalloproteinase-2 inhibition. Biochem Pharmacol. 130:10–20. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Wang H, Liu Y, Wang C, Wang J,
Long C, Guo W and Sun X: Baicalein inhibits growth of Epstein-Barr
virus-positive nasopharyngeal carcinoma by repressing the activity
of EBNA1 Q-promoter. Biomed Pharmacother. 102:1003–1014. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou H, Liu Y, Wang C, Liu L, Wang H,
Zhang Y, Long C and Sun X: Triptolide inhibits Epstein-Barr nuclear
antigen 1 expression by increasing sensitivity of mitochondria
apoptosis of nasopharyngeal carcinoma cells. J Exp Clin Cancer Res.
37:1922018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou H, Guo W, Long C, Wang H, Wang J and
Sun X: Triptolide inhibits proliferation of Epstein-Barr
virus-positive B lymphocytes by down-regulating expression of a
viral protein LMP1. Biochem Biophys Res Commun. 456:815–820. 2015.
View Article : Google Scholar
|
|
26
|
Banerjee S, Sangwan V, McGinn O, Chugh R,
Dudeja V, Vickers SM and Saluja AK: Triptolide-induced cell death
in pancreatic cancer is mediated by O-GlcNAc modification of
transcription factor Sp1. J Biol Chem. 288:33927–33938. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yao JC, Wang L, Wei D, Gong W, Hassan M,
Wu TT, Mansfield P, Ajani J and Xie K: Association between
expression of transcription factor Sp1 and increased vascular
endothelial growth factor expression, advanced stage, and poor
survival in patients with resected gastric cancer. Clin Cancer Res.
10:4109–4117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Enya K, Hayashi H, Takii T, Ohoka N,
Kanata S, Okamoto T and Onozaki K: The interaction with Sp1 and
reduction in the activity of histone deacetylase 1 are critical for
the constitu-tive gene expression of IL-1 alpha in human melanoma
cells. J Leukoc Biol. 83:190–199. 2008. View Article : Google Scholar
|
|
29
|
Shin JA, Kim JJ, Choi ES, Shim JH, Ryu MH,
Kwon KH, Park HM, Seo JY, Lee SY, Lim DW, et al: In vitro apoptotic
effects of methanol extracts of dianthus chinensis and acalypha
australis L. targeting specificity protein 1 in human oral cancer
cells. Head Neck. 35:992–998. 2013. View Article : Google Scholar
|
|
30
|
Fox JT, Sakamuru S, Huang R, Teneva N,
Simmons SO, Xia M, Tice RR, Austin CP and Myung K: High-throughput
genotoxicity assay identifies antioxidants as inducers of DNA
damage response and cell death. Proc Natl Acad Sci USA.
109:5423–5428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu J, Liu H, Lei J, Tan W, Hu X and Zou G:
Antitumor activity of chloroform fraction of Scutellaria barbata
and its active constituents. Phytother Res. 21:817–822. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong WY, Zhao ZX, Liu BJ, Lu LW and Dong
JC: Exploring the chemopreventive properties and perspectives of
baicalin and its aglycone baicalein in solid tumors. Eur J Med
Chem. 126:844–852. 2017. View Article : Google Scholar
|
|
33
|
Baumann S, Fas SC, Giaisi M, Müller WW,
Merling A, Gülow K, Edler L, Krammer PH and Li-Weber M: Wogonin
preferentially kills malignant lymphocytes and suppresses T-cell
tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis.
Blood. 111:2354–2363. 2008. View Article : Google Scholar
|
|
34
|
Zhou QM, Wang S, Zhang H, Lu YY, Wang XF,
Motoo Y and Su SB: The combination of baicalin and baicalein
enhances apoptosis via the ERK/p38 MAPK pathway in human breast
cancer cells. Acta Pharmacol Sin. 30:1648–1658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao J, Morgan WA, Sanchez-Medina A and
Corcoran O: The ethanol extract of Scutellaria baicalensis and the
active compounds induce cell cycle arrest and apoptosis including
upregulation of p53 and Bax in human lung cancer cells. Toxicol
Appl Pharmacol. 254:221–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ling Y, Chen Y, Chen P, Hui H, Song X, Lu
Z, Li C, Lu N and Guo Q: Baicalein potently suppresses angiogenesis
induced by vascular endothelial growth factor through the p53/Rb
signaling pathway leading to G1/S cell cycle arrest. Exp Biol Med
(Maywood). 236:851–858. 2011. View Article : Google Scholar
|
|
37
|
Chen CH, Huang TS, Wong CH, Hong CL, Tsai
YH, Liang CC, Lu FJ and Chang WH: Synergistic anti-cancer effect of
baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem
Toxicol. 47:638–644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dou J, Wang Z, Ma L, Peng B, Mao K, Li C,
Su M, Zhou C and Peng G: Baicalein and baicalin inhibit colon
cancer using two distinct fashions of apoptosis and senescence.
Oncotarget. 9:20089–20102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tian Y, Zhen L, Bai J, Mei Y, Li Z, Lin A
and Li X: Anticancer effects of baicalein in pancreatic
neuroendocrine tumors in vitro and in vivo. Pancreas. 46:1076–1081.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sachita K, Yu HJ, Yun JW, Lee JS and Cho
SD: YM155 induces apoptosis through downregulation of specificity
protein 1 and myeloid cell leukemia-1 in human oral cancer cell
lines. J Oral Pathol Med. 44:785–791. 2015. View Article : Google Scholar
|
|
41
|
Cho JH, Lee RH, Jeon YJ, Shin JC, Park SM,
Choi NJ, Seo KS, Yoon G, Cho SS, Kim KH, et al: Role of
transcription factor Sp1 in the 4-O-methylhonokiol-mediated
apoptotic effect on oral squamous cancer cells and xenograft. Int J
Biochem Cell Biol. 64:287–297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Druzgal CH, Chen Z, Yeh NT, Thomas GR,
Ondrey FG, Duffey DC, Vilela RJ, Ende K, McCullagh L, Rudy SF, et
al: A pilot study of longitudinal serum cytokine and angiogenesis
factor levels as markers of therapeutic response and survival in
patients with head and neck squamous cell carcinoma. Head Neck.
27:771–784. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bond M, Fabunmi RP, Baker AH and Newby AC:
Synergistic upregulation of metalloproteinase-9 by growth factors
and inflammatory cytokines: An absolute requirement for
transcription factor NF-kappa. B FEBS Lett. 435:29–34. 1998.
View Article : Google Scholar
|
|
44
|
Mburu YK, Egloff AM, Walker WH, Wang L,
Seethala RR, van Waes C and Ferris RL: Chemokine receptor 7 (CCR7)
gene expression is regulated by NF-κB and activator protein 1 (AP1)
in metastatic squamous cell carcinoma of head and neck (SCCHN). J
Biol Chem. 287:3581–3590. 2012. View Article : Google Scholar
|
|
45
|
Lee E, Park HR, Ji ST, Lee Y and Lee J:
Baicalein attenuates astroglial activation in the
1-methyl-4-phenyl-1,2,3,4-tetrahydro-pyridine-induced Parkinson's
disease model by downregulating the activations of nuclear
factor-κB, ERK, and JNK. J Neurosci Res. 92:130–139. 2014.
View Article : Google Scholar
|
|
46
|
Sahu BD, Mahesh Kumar J and Sistla R:
Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney
injury by up-regulating antioxidant defenses and down-regulating
the MAPKs and NF-κB Pathways. PloS One. 10:e01341392015. View Article : Google Scholar
|
|
47
|
Wan CX, Xu M, Huang SH, Wu QQ, Yuan Y,
Deng W and Tang QZ: Baicalein protects against endothelial cell
injury by inhibiting the TLR4/NFkB signaling pathway. Mol Med Rep.
17:3085–3091. 2018.
|
|
48
|
Yu X, Liu Y, Wang Y, Mao X, Zhang Y and
Xia J: Baicalein induces cervical cancer apoptosis through the
NF-κB signaling pathway. Mol Med Rep. 17:5088–5094. 2018.PubMed/NCBI
|
|
49
|
Yu X, Tang W, Yang Y, Tang L, Dai R, Pu B,
Feng C and Xia J: Long noncoding RNA NKILA enhances the anti-cancer
effects of baicalein in hepatocellular carcinoma via the regulation
of NF-κB signaling. Chem Biol Interactions. 285:48–58. 2018.
View Article : Google Scholar
|
